Mylan (MYL): Today's Pre-Market Leader Stock

Trade-Ideas LLC identified Mylan (MYL) as a pre-market leader candidate
By TheStreet Wire ,

Trade-Ideas LLC identified

Mylan

(

MYL

) as a pre-market leader candidate. In addition to specific proprietary factors, Trade-Ideas identified Mylan as such a stock due to the following factors:

  • MYL has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $471.6 million.
  • MYL traded 159,647 shares today in the pre-market hours as of 7:26 AM.
  • MYL is up 12.9% today from yesterday's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in MYL with the Ticky from Trade-Ideas. See the FREE profile for MYL NOW at Trade-Ideas

More details on MYL:

Mylan N.V., through its subsidiaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. MYL has a PE ratio of 21. Currently there are 4 analysts that rate Mylan a buy, no analysts rate it a sell, and 4 rate it a hold.

The average volume for Mylan has been 8.4 million shares per day over the past 30 days. Mylan has a market cap of $22.3 billion and is part of the health care sector and drugs industry. The stock has a beta of 1.36 and a short float of 16% with 6.92 days to cover. Shares are down 21.1% year-to-date as of the close of trading on Wednesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

TheStreetRatings.com

Analysis:

TheStreet Quant Ratings

rates Mylan as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, attractive valuation levels, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had sub par growth in net income.

Highlights from the ratings report include:

  • The revenue growth greatly exceeded the industry average of 7.1%. Since the same quarter one year prior, revenues rose by 29.3%. This growth in revenue does not appear to have trickled down to the company's bottom line, displayed by a decline in earnings per share.
  • Net operating cash flow has significantly increased by 121.19% to $974.80 million when compared to the same quarter last year. In addition, MYLAN NV has also vastly surpassed the industry average cash flow growth rate of -17.22%.
  • The gross profit margin for MYLAN NV is rather high; currently it is at 59.48%. It has increased from the same quarter the previous year. Despite the strong results of the gross profit margin, MYL's net profit margin of 15.90% significantly trails the industry average.
  • The debt-to-equity ratio is somewhat low, currently at 0.65, and is less than that of the industry average, implying that there has been a relatively successful effort in the management of debt levels. Although the company had a strong debt-to-equity ratio, its quick ratio of 0.98 is somewhat weak and could be cause for future problems.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Loading ...